company background image

NuVasive NasdaqGS:NUVA Stock Report

Last Price


Market Cap







14 Aug, 2022


Company Financials +
NUVA fundamental analysis
Snowflake Score
Future Growth3/6
Past Performance0/6
Financial Health3/6

NUVA Stock Overview

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.

NuVasive, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NuVasive
Historical stock prices
Current Share PriceUS$53.49
52 Week HighUS$64.43
52 Week LowUS$45.45
1 Month Change7.50%
3 Month Change2.00%
1 Year Change-8.64%
3 Year Change-16.06%
5 Year Change-16.50%
Change since IPO369.21%

Recent News & Updates

Aug 11
Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Aug 03

NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M

NuVasive press release (NASDAQ:NUVA): Q2 Non-GAAP EPS of $0.47 misses by $0.09. Revenue of $310.5M (+5.3% Y/Y) beats by $4.12M.

Shareholder Returns

NUVAUS Medical EquipmentUS Market

Return vs Industry: NUVA exceeded the US Medical Equipment industry which returned -19.1% over the past year.

Return vs Market: NUVA exceeded the US Market which returned -10.2% over the past year.

Price Volatility

Is NUVA's price volatile compared to industry and market?
NUVA volatility
NUVA Average Weekly Movement5.4%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.7%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: NUVA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: NUVA's weekly volatility (5%) has been stable over the past year.

About the Company

19972,900Chris Barry

NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room.

NuVasive, Inc. Fundamentals Summary

How do NuVasive's earnings and revenue compare to its market cap?
NUVA fundamental statistics
Market CapUS$2.78b
Earnings (TTM)-US$40.07m
Revenue (TTM)US$1.17b


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NUVA income statement (TTM)
Cost of RevenueUS$337.04m
Gross ProfitUS$837.08m
Other ExpensesUS$877.15m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)-0.77
Gross Margin71.29%
Net Profit Margin-3.41%
Debt/Equity Ratio107.5%

How did NUVA perform over the long term?

See historical performance and comparison